Bispecific antibody therapy has generated excitement among cancer researchers in recent years as a way to treat certain cancers. Krishna Ghimire, MD, explains the promise of bispecific antibodies for a variety of cancers and other diseases. He is an assistant professor of medicine at Upstate, specializing in hematology and medical oncology.
“The Informed Patient” is a podcast that covers health, science and medicine, featuring experts from Central New York’s only academic medical center. Upstate Medical University has four colleges (Medicine, Nursing, Health Professions and Graduate Studies); a robust research enterprise; and an extensive clinical health care system that extends way beyond Syracuse.
For more information, please visit: https://www.upstate.edu/informed/
“The Informed Patient” is a podcast that covers health, science and medicine, featuring experts from Central New York’s only academic medical center. Upstate Medical University has four colleges (Medicine, Nursing, Health Professions and Graduate Studies); a robust research enterprise; and an extensive clinical health care system that extends way beyond Syracuse.
For more information, please visit: https://www.upstate.edu/informed/
- Category
- Oncology

Be the first to comment